A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
62 locations incl. Huntsville
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
Mary Bird Perkins Cancer Center - Metairie
Clinical research site in Metairie, Louisiana
Part of Mary Bird Perkins Cancer Center
As of July 2026, 10 paid clinical trials are recruiting at Mary Bird Perkins Cancer Center - Metairie in Metairie, Louisiana. Active studies at this site cover conditions such as Muscle Invasive Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v8 and Stage IV Renal Cell Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Mary Bird Perkins Cancer Center - Metairie (10)
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for Muscle Invasive Bladder Urothelial Carcinoma
449 locations incl. Phoenix
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05987241·Phase 2, Phase 3·Recruiting·Listed Aug 2023
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
for Bladder Adenocarcinoma
224 locations incl. Phoenix
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT03866382·Phase 2·Recruiting·Listed Mar 2019
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for Prostate Cancer (Adenocarcinoma)
359 locations incl. Anchorage
Sponsor: Canadian Cancer Trials Group
Sex: Male·Age: 18+
Code: NCT06592924·Phase 3·Recruiting·Listed Sep 2024
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for Metastatic Renal Cell Carcinoma
280 locations incl. Kingman
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05327686·Phase 2·Recruiting·Listed Apr 2022
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for Renal Pelvis and Ureter Urothelial Carcinoma
152 locations incl. Kingman
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT04628767·Phase 2, Phase 3·Recruiting·Listed Nov 2020
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
for Non-Muscle Invasive Bladder Urothelial Carcinoma
127 locations incl. Fayetteville
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06770582·Phase 2·Recruiting·Listed Jan 2025
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
for Locally Advanced Urothelial Carcinoma
150 locations incl. Phoenix
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06524544·Phase 3·Recruiting·Listed Jul 2024
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for Muscle Invasive Bladder Urothelial Carcinoma
208 locations incl. Fort Smith
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT07097142·Phase 3·Recruiting·Listed Jul 2025
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
for Recurrent Non-Muscle Invasive Bladder Carcinoma
58 locations incl. Birmingham
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT07000084·Phase 3·Recruiting·Listed May 2025
More research sites in Metairie
- East Jefferson General Hospital (14 trials)
- LSU Healthcare Network / Metairie Multi-Specialty Clinic (8 trials)
- GI Alliance (4 trials)
- Tandem Clinical Research (4 trials)
- Clinical Trials Management, LLC (3 trials)
- East Jefferson Hospital (3 trials)
- Omega Clinical Research (3 trials)
- Akero Clinical Study Site (2 trials)
- Tandem Clinical Research - Metairie Clinic (2 trials)
- GI Alliance - Metairie (2 trials)
Explore more
Paid clinical trials in Metairie, LA · Louisiana clinical trials